Skip to main content
Reset

Advanced Filters

Advanced Search Help

Standard search functionality is for the search to return results that contain all words entered into the search bar.

Exact Phrase Match Search - Use quotations around a phrase to only return results that are an exact match to the search term entered. Example: "example text"

Exclusion Search - Use the minus sign to only return results that do not include your search term. -example

Either/Or Search - Use the word OR in between words to return results that include either or both words. Example: example OR test

Use advanced filters to allow you to further drill down and limit your search results! Such as selecting two dates to only display matching search results which occur on either of those days.

Search options can be combined in limited ways to increase the accuracy of your search results. Example: A search for "intellectual property" and electrochemistry.

Advanced Filters
  • Displaying 10 - 20 of 43
  • First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last
Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital SettingTreatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting
Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting
Dr. Dariusz Uczkowski, MD, Author
Tags: Clinical Oncology
View Poster


Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting



Author(s):
  • Dr. Dariusz Uczkowski, MD

Tags: Clinical Oncology
MC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib in Combination with Pembrolizumab in Patients with FGF19 Expressing Advanced or Metastatic Hepatocellular CarcinomaMC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib in Combination with Pembrolizumab in Patients with FGF19 Expressing Advanced or Metastatic Hepatocellular Carcinoma
MC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib in Combination with Pembrolizumab in Patients with FGF19 Expressing Advanced or Metastatic Hepatocellular Carcinoma
Nguyen H. Tran, MD, Author
Tags: Member Institution Clinical Oncology ORP
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Nguyen H. Tran, MD

Tags: Member Institution Clinical Oncology ORP
Comparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-term DataComparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-term Data
Comparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-term Data
Dr. Abdenour Nabid, MD, FCRP(C), Author
Tags: Clinical Oncology
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Dr. Abdenour Nabid, MD, FCRP(C)

Tags: Clinical Oncology
Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Breast and Non-Small Cell Lung Cancer (NSCLC)Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Breast and Non-Small Cell Lung Cancer (NSCLC)
Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Breast and Non-Small Cell Lung Cancer (NSCLC)
Mr. Mason Alford, MSc, Author
Tags: Member Institution Clinical Oncology
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Mr. Mason Alford, MSc

Tags: Member Institution Clinical Oncology
Total Neoadjuvant Chemotherapy Followed by HIPEC and Curative Surgery in Treatment of Locally Advanced Gastric CancerTotal Neoadjuvant Chemotherapy Followed by HIPEC and Curative Surgery in Treatment of Locally Advanced Gastric Cancer
Total Neoadjuvant Chemotherapy Followed by HIPEC and Curative Surgery in Treatment of Locally Advanced Gastric Cancer
Dr Veronika Patsko, MD, Author
Tags: Clinical Oncology
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Dr Veronika Patsko, MD

Tags: Clinical Oncology
Do Proton Pump Inhibitors Affect the Effectiveness of Capecitabine-Based Chemotherapy in Colorectal Cancers? A Systematic Review with Meta-AnalysisDo Proton Pump Inhibitors Affect the Effectiveness of Capecitabine-Based Chemotherapy in Colorectal Cancers? A Systematic Review with Meta-Analysis
Do Proton Pump Inhibitors Affect the Effectiveness of Capecitabine-Based Chemotherapy in Colorectal Cancers? A Systematic Review with Meta-Analysis
Chin-Hsuan Huang, MD, Author
Tags: Clinical Oncology
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Chin-Hsuan Huang, MD

Tags: Clinical Oncology
Early Interim Analysis of a Phase II Randomized Trial of Moderate Versus Ultrahypofractionated Post-Prostatectomy Radiation TherapyEarly Interim Analysis of a Phase II Randomized Trial of Moderate Versus Ultrahypofractionated Post-Prostatectomy Radiation Therapy
Early Interim Analysis of a Phase II Randomized Trial of Moderate Versus Ultrahypofractionated Post-Prostatectomy Radiation Therapy

Tags: Member Institution NCCN Foundation Young Investigator Award Clinical Oncology
View Poster


YIA23-005: https://jnccn.org/view/journal...


Tags: Member Institution NCCN Foundation Young Investigator Award Clinical Oncology
Non-melanoma Skin Cancer (NMSC) in Patients with Chronic Lymphocytic Leukemia (CLL): Biology and PreventionNon-melanoma Skin Cancer (NMSC) in Patients with Chronic Lymphocytic Leukemia (CLL): Biology and Prevention
Non-melanoma Skin Cancer (NMSC) in Patients with Chronic Lymphocytic Leukemia (CLL): Biology and Prevention
Deborah M. Stephens, DO, Author
Tags: Member Institution NCCN Foundation Young Investigator Award Clinical Oncology
View Poster


YIA23-004: https://jnccn.org/view/journal...



Author(s):
  • Deborah M. Stephens, DO

Tags: Member Institution NCCN Foundation Young Investigator Award Clinical Oncology
CD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical ResponseCD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical Response
CD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical Response
Caitlin Zebley, MD, PhD, Author
Tags: Member Institution NCCN Foundation Young Investigator Award Clinical Oncology
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Caitlin Zebley, MD, PhD

Tags: Member Institution NCCN Foundation Young Investigator Award Clinical Oncology
Effectiveness and Toxicity of Cetuximab with Concurrent RT in Locally Advanced Cutaneous Squamous Cell Skin Cancer: A Case SeriesEffectiveness and Toxicity of Cetuximab with Concurrent RT in Locally Advanced Cutaneous Squamous Cell Skin Cancer: A Case Series
Effectiveness and Toxicity of Cetuximab with Concurrent RT in Locally Advanced Cutaneous Squamous Cell Skin Cancer: A Case Series
Dr. Mark Joshua Chang, DO, Author
Tags: Clinical Oncology
View Poster


https://jnccn.org/view/journal...



Author(s):
  • Dr. Mark Joshua Chang, DO

Tags: Clinical Oncology
  • Displaying 10 - 20 of 43
  • First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last